Literature DB >> 870434

Immune response in rabbits to virion and nonvirion antigens of the Flavivirus kunjin.

A J Della-Porta, E G Westaway.   

Abstract

The nature of the antibodies formed in rabbits in response to the following Kunjin virus antigens was examined: infectious suckling mouse brain (SMB), purified virion or rapidly sedimenting hemagglutinin (RHA), slowly sedimenting hemagglutinin (SHA), and envelope fragments prepared from RHA disrupted by 0.1 or 0.2% sodium deoxycholate (DOC). The hemagglutination-inhibiting (HI) and neutralizing antibody responses to SMB, RHA, and large envelope fragments (0.1% DOC) were remarkably uniform, antibodies appearing at the same time, attaining similar HI titers (lowest to envelope), and being of similar avidity early and late in the respone. The 19S (immunoglobulin M) antibodies to all antigens were always relatively type-specific, whereas the 7S (immunoglobulin G) antibodies were always broadly cross-reactive in HI tests. These results confirm that the envelope antigen is the principal antigen involved in the stimulation of protective neutralizing antibodies and contains both type- and group-specific antigenic determinants. The results also establish that there is no significant advantage in using purified RHA or SHA either for immunization or as hemagglutinin antigens in attempts to obtain greater specificity in the HI test. No differences were detected in the antibody responses to infective Kunjin virus, within the range 1,400 to 10(9) plaque-forming units (PFU). Below 1,400 PFU, there was no detectable response. Inactivated virus (10(6) PFU) also stimulated the normal antibody response. In contrast, small envelope fragments (derived with 0.2% DOC) and a detergent-solubilized extract of infected cells were unable to stimulate a detectable antibody response and the small envelope fragments may have induced low dose tolerance in one of two rabbits.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870434      PMCID: PMC421455          DOI: 10.1128/iai.15.3.874-882.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Particle counts and some chemical properties of Murray Valley encephalitis virus.

Authors:  G L ADA; A ABBOT; S G ANDERSON; F D COLLINS
Journal:  J Gen Microbiol       Date:  1962-09

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  Human immunoglobulin M antibody in the sero-diagnosis of Japanese encephalitis virus infections.

Authors:  R Edelman; A Pariyanonda
Journal:  Am J Epidemiol       Date:  1973-07       Impact factor: 4.897

4.  Role of macrophages and antibody in resistance of mice against yellow fever virus.

Authors:  B Zisman; E F Wheelock; A C Allison
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

5.  Group B arbovirus structural and nonstructural antigens. 3. Serological specificity of solubilized intracellular viral proteins.

Authors:  A A Qureshi; D W Trent
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

6.  Physical and biological properties of dengue-2 virus and associated antigens.

Authors:  T J Smith; W E Brandt; J L Swanson; J M McCown; E L Buescher
Journal:  J Virol       Date:  1970-04       Impact factor: 5.103

7.  Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses.

Authors:  E G Westaway
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

8.  Antibody responses in rabbits to the group B arbovirus Kumjin: serologic activity of the fractionated immunoglobulins in homologous and heterologous reactions.

Authors:  E G Westaway
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

9.  Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.

Authors:  R A Mason; N M Tauraso; R K Ginn; T C O'Brien; R W Trimmer
Journal:  Appl Microbiol       Date:  1972-05

10.  Dose-dependent viremia and the differential immunoglobulin response of hamsters to Powassan virus.

Authors:  M A Chernesky; P J Whittaker-Haines
Journal:  Can J Microbiol       Date:  1972-05       Impact factor: 2.419

View more
  9 in total

1.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.

Authors:  Erin Mehlhop; Camilo Ansarah-Sobrinho; Syd Johnson; Michael Engle; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

2.  Flavivirus infection: essential ultrastructural changes and association of Kunjin virus NS3 protein with microtubules.

Authors:  M L Ng; S S Hong
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Variation in distribution of the three flavivirus-specified glycoproteins detected by immunofluorescence in infected Vero cells.

Authors:  E G Westaway; M R Goodman
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 4.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

5.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

6.  Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

Authors:  Erin Mehlhop; Steevenson Nelson; Christiane A Jost; Sergey Gorlatov; Syd Johnson; Daved H Fremont; Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

7.  Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins.

Authors:  F X Heinz; W Tuma; C Kunz
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody.

Authors:  T Trirawatanapong; B Chandran; R Putnak; R Padmanabhan
Journal:  Gene       Date:  1992-07-15       Impact factor: 3.688

Review 9.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.